Elequin Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Elequin Capital’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134	Closed	-$17.2K	–	604
2022 Q4	$17.2K	Buy	+134	New	+$17.3K	﹤0.01%	415

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Elequin Capital's SGEN Position: Q1 2023 in Review

Elequin Capital sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 134 shares — an estimated $17.2K sold.

Elequin Capital first reported a position in SGEN in Q4 2022 and held it in 1 quarter. The position peaked at $17.2K in Q4 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

Elequin Capital reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Elequin Capital sold 134 Seagen Inc. Common Stock shares in Q1 2023, an estimated $17.2K.
Elequin Capital first reported a position in Seagen Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Elequin Capital's Seagen Inc. Common Stock position peaked at $17.2K in Q4 2022.
575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.